wy 45911 has been researched along with bwa 4c in 1 studies
| Studies (wy 45911) | Trials (wy 45911) | Recent Studies (post-2010) (wy 45911) | Studies (bwa 4c) | Trials (bwa 4c) | Recent Studies (post-2010) (bwa 4c) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 74 | 0 | 16 |
| Protein | Taxonomy | wy 45911 (IC50) | bwa 4c (IC50) |
|---|---|---|---|
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 0.1976 | |
| Arachidonate 5-lipoxygenase-activating protein | Homo sapiens (human) | 0.11 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 3.2 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 3.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kreft, AF; Musser, JH | 1 |
1 review(s) available for wy 45911 and bwa 4c
| Article | Year |
|---|---|
5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors.
Topics: Animals; Arachidonate 5-Lipoxygenase; Asthma; Eosinophils; Humans; Inflammation; Leukotriene Antagonists; Lipoxygenase Inhibitors; Lung Diseases; Neutrophils; Quinolines | 1992 |